nodes	percent_of_prediction	percent_of_DWPC	metapath
Etonogestrel—CYP3A4—Topotecan—lung cancer	0.0561	0.142	CbGbCtD
Etonogestrel—CYP3A4—Gefitinib—lung cancer	0.0513	0.13	CbGbCtD
Etonogestrel—CYP3A4—Teniposide—lung cancer	0.0498	0.126	CbGbCtD
Etonogestrel—CYP3A4—Vinorelbine—lung cancer	0.0395	0.1	CbGbCtD
Etonogestrel—CYP3A4—Crizotinib—lung cancer	0.0315	0.0796	CbGbCtD
Etonogestrel—CYP3A4—Erlotinib—lung cancer	0.0304	0.0768	CbGbCtD
Etonogestrel—CYP3A4—Paclitaxel—lung cancer	0.0278	0.0703	CbGbCtD
Etonogestrel—CYP3A4—Irinotecan—lung cancer	0.0274	0.0694	CbGbCtD
Etonogestrel—CYP3A4—Vinblastine—lung cancer	0.0244	0.0617	CbGbCtD
Etonogestrel—CYP3A4—Etoposide—lung cancer	0.022	0.0556	CbGbCtD
Etonogestrel—CYP3A4—Docetaxel—lung cancer	0.0201	0.0508	CbGbCtD
Etonogestrel—CYP3A4—Doxorubicin—lung cancer	0.015	0.0379	CbGbCtD
Etonogestrel—Body temperature increased—Irinotecan—lung cancer	0.000268	0.000605	CcSEcCtD
Etonogestrel—Decreased appetite—Cisplatin—lung cancer	0.000268	0.000604	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Cisplatin—lung cancer	0.000266	0.0006	CcSEcCtD
Etonogestrel—Infestation NOS—Methotrexate—lung cancer	0.000265	0.000598	CcSEcCtD
Etonogestrel—Infestation—Methotrexate—lung cancer	0.000265	0.000598	CcSEcCtD
Etonogestrel—Depression—Methotrexate—lung cancer	0.000264	0.000596	CcSEcCtD
Etonogestrel—Anorexia—Paclitaxel—lung cancer	0.000264	0.000595	CcSEcCtD
Etonogestrel—Gastritis—Doxorubicin—lung cancer	0.000264	0.000595	CcSEcCtD
Etonogestrel—Pain—Cisplatin—lung cancer	0.000263	0.000595	CcSEcCtD
Etonogestrel—Vomiting—Vinorelbine—lung cancer	0.000262	0.00059	CcSEcCtD
Etonogestrel—Body temperature increased—Gemcitabine—lung cancer	0.000261	0.00059	CcSEcCtD
Etonogestrel—Rash—Vinorelbine—lung cancer	0.000259	0.000585	CcSEcCtD
Etonogestrel—Dermatitis—Vinorelbine—lung cancer	0.000259	0.000585	CcSEcCtD
Etonogestrel—Abdominal distension—Doxorubicin—lung cancer	0.000259	0.000585	CcSEcCtD
Etonogestrel—Headache—Vinorelbine—lung cancer	0.000258	0.000582	CcSEcCtD
Etonogestrel—Asthma—Doxorubicin—lung cancer	0.000257	0.000581	CcSEcCtD
Etonogestrel—Testosterone—ABCG2—lung cancer	0.000257	0.175	CrCbGaD
Etonogestrel—Feeling abnormal—Cisplatin—lung cancer	0.000254	0.000573	CcSEcCtD
Etonogestrel—Paraesthesia—Etoposide—lung cancer	0.000253	0.000572	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000252	0.000569	CcSEcCtD
Etonogestrel—Somnolence—Etoposide—lung cancer	0.000251	0.000566	CcSEcCtD
Etonogestrel—Cough—Docetaxel—lung cancer	0.000251	0.000566	CcSEcCtD
Etonogestrel—Insomnia—Paclitaxel—lung cancer	0.00025	0.000565	CcSEcCtD
Etonogestrel—Hypersensitivity—Irinotecan—lung cancer	0.00025	0.000564	CcSEcCtD
Etonogestrel—Convulsion—Docetaxel—lung cancer	0.000249	0.000562	CcSEcCtD
Etonogestrel—Paraesthesia—Paclitaxel—lung cancer	0.000249	0.000561	CcSEcCtD
Etonogestrel—Hypertension—Docetaxel—lung cancer	0.000248	0.00056	CcSEcCtD
Etonogestrel—Bronchitis—Doxorubicin—lung cancer	0.000248	0.000559	CcSEcCtD
Etonogestrel—Somnolence—Paclitaxel—lung cancer	0.000246	0.000555	CcSEcCtD
Etonogestrel—Decreased appetite—Etoposide—lung cancer	0.000245	0.000554	CcSEcCtD
Etonogestrel—Arthralgia—Docetaxel—lung cancer	0.000245	0.000552	CcSEcCtD
Etonogestrel—Myalgia—Docetaxel—lung cancer	0.000245	0.000552	CcSEcCtD
Etonogestrel—Nausea—Vinorelbine—lung cancer	0.000244	0.000551	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Etoposide—lung cancer	0.000244	0.00055	CcSEcCtD
Etonogestrel—Dyspepsia—Paclitaxel—lung cancer	0.000244	0.00055	CcSEcCtD
Etonogestrel—Body temperature increased—Cisplatin—lung cancer	0.000244	0.00055	CcSEcCtD
Etonogestrel—Asthenia—Irinotecan—lung cancer	0.000243	0.000549	CcSEcCtD
Etonogestrel—Fatigue—Etoposide—lung cancer	0.000243	0.000549	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000243	0.000548	CcSEcCtD
Etonogestrel—Constipation—Etoposide—lung cancer	0.000241	0.000545	CcSEcCtD
Etonogestrel—Pain—Etoposide—lung cancer	0.000241	0.000545	CcSEcCtD
Etonogestrel—Dysuria—Doxorubicin—lung cancer	0.000241	0.000543	CcSEcCtD
Etonogestrel—Decreased appetite—Paclitaxel—lung cancer	0.000241	0.000543	CcSEcCtD
Etonogestrel—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000239	0.00054	CcSEcCtD
Etonogestrel—Haemoglobin—Methotrexate—lung cancer	0.000239	0.00054	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000239	0.000539	CcSEcCtD
Etonogestrel—Fatigue—Paclitaxel—lung cancer	0.000239	0.000538	CcSEcCtD
Etonogestrel—Haemorrhage—Methotrexate—lung cancer	0.000238	0.000537	CcSEcCtD
Etonogestrel—Pollakiuria—Doxorubicin—lung cancer	0.000238	0.000537	CcSEcCtD
Etonogestrel—Asthenia—Gemcitabine—lung cancer	0.000237	0.000535	CcSEcCtD
Etonogestrel—Constipation—Paclitaxel—lung cancer	0.000237	0.000534	CcSEcCtD
Etonogestrel—Pain—Paclitaxel—lung cancer	0.000237	0.000534	CcSEcCtD
Etonogestrel—Pharyngitis—Methotrexate—lung cancer	0.000236	0.000533	CcSEcCtD
Etonogestrel—Urinary tract disorder—Methotrexate—lung cancer	0.000235	0.00053	CcSEcCtD
Etonogestrel—Anaphylactic shock—Docetaxel—lung cancer	0.000235	0.000529	CcSEcCtD
Etonogestrel—Oedema—Docetaxel—lung cancer	0.000235	0.000529	CcSEcCtD
Etonogestrel—Weight increased—Doxorubicin—lung cancer	0.000234	0.000529	CcSEcCtD
Etonogestrel—Pruritus—Gemcitabine—lung cancer	0.000234	0.000528	CcSEcCtD
Etonogestrel—Urethral disorder—Methotrexate—lung cancer	0.000233	0.000526	CcSEcCtD
Etonogestrel—Infection—Docetaxel—lung cancer	0.000233	0.000526	CcSEcCtD
Etonogestrel—Weight decreased—Doxorubicin—lung cancer	0.000233	0.000526	CcSEcCtD
Etonogestrel—Feeling abnormal—Etoposide—lung cancer	0.000233	0.000525	CcSEcCtD
Etonogestrel—Diarrhoea—Irinotecan—lung cancer	0.000232	0.000524	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Etoposide—lung cancer	0.000231	0.000521	CcSEcCtD
Etonogestrel—Nervous system disorder—Docetaxel—lung cancer	0.00023	0.000519	CcSEcCtD
Etonogestrel—Infestation NOS—Doxorubicin—lung cancer	0.00023	0.000518	CcSEcCtD
Etonogestrel—Infestation—Doxorubicin—lung cancer	0.00023	0.000518	CcSEcCtD
Etonogestrel—Visual impairment—Methotrexate—lung cancer	0.000229	0.000517	CcSEcCtD
Etonogestrel—Feeling abnormal—Paclitaxel—lung cancer	0.000228	0.000515	CcSEcCtD
Etonogestrel—Skin disorder—Docetaxel—lung cancer	0.000228	0.000514	CcSEcCtD
Etonogestrel—Hypersensitivity—Cisplatin—lung cancer	0.000227	0.000512	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Paclitaxel—lung cancer	0.000226	0.000511	CcSEcCtD
Etonogestrel—Diarrhoea—Gemcitabine—lung cancer	0.000226	0.00051	CcSEcCtD
Etonogestrel—Neuropathy peripheral—Doxorubicin—lung cancer	0.000225	0.000508	CcSEcCtD
Etonogestrel—Dizziness—Irinotecan—lung cancer	0.000224	0.000506	CcSEcCtD
Etonogestrel—Urticaria—Etoposide—lung cancer	0.000224	0.000506	CcSEcCtD
Etonogestrel—Anorexia—Docetaxel—lung cancer	0.000224	0.000505	CcSEcCtD
Etonogestrel—Body temperature increased—Etoposide—lung cancer	0.000223	0.000504	CcSEcCtD
Etonogestrel—Abdominal pain—Etoposide—lung cancer	0.000223	0.000504	CcSEcCtD
Etonogestrel—Urinary tract infection—Doxorubicin—lung cancer	0.000223	0.000503	CcSEcCtD
Etonogestrel—Eye disorder—Methotrexate—lung cancer	0.000222	0.000502	CcSEcCtD
Etonogestrel—Asthenia—Cisplatin—lung cancer	0.000221	0.000499	CcSEcCtD
Etonogestrel—Urticaria—Paclitaxel—lung cancer	0.00022	0.000496	CcSEcCtD
Etonogestrel—Abdominal pain—Paclitaxel—lung cancer	0.000219	0.000494	CcSEcCtD
Etonogestrel—Body temperature increased—Paclitaxel—lung cancer	0.000219	0.000494	CcSEcCtD
Etonogestrel—Angiopathy—Methotrexate—lung cancer	0.000216	0.000487	CcSEcCtD
Etonogestrel—Vomiting—Irinotecan—lung cancer	0.000216	0.000487	CcSEcCtD
Etonogestrel—Sinusitis—Doxorubicin—lung cancer	0.000215	0.000486	CcSEcCtD
Etonogestrel—Immune system disorder—Methotrexate—lung cancer	0.000215	0.000485	CcSEcCtD
Etonogestrel—Rash—Irinotecan—lung cancer	0.000214	0.000483	CcSEcCtD
Etonogestrel—Dermatitis—Irinotecan—lung cancer	0.000214	0.000482	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000214	0.000482	CcSEcCtD
Etonogestrel—Headache—Irinotecan—lung cancer	0.000213	0.00048	CcSEcCtD
Etonogestrel—Insomnia—Docetaxel—lung cancer	0.000212	0.000479	CcSEcCtD
Etonogestrel—Diarrhoea—Cisplatin—lung cancer	0.000211	0.000476	CcSEcCtD
Etonogestrel—Paraesthesia—Docetaxel—lung cancer	0.000211	0.000475	CcSEcCtD
Etonogestrel—Alopecia—Methotrexate—lung cancer	0.00021	0.000475	CcSEcCtD
Etonogestrel—Vomiting—Gemcitabine—lung cancer	0.00021	0.000474	CcSEcCtD
Etonogestrel—Somnolence—Docetaxel—lung cancer	0.000209	0.000471	CcSEcCtD
Etonogestrel—Mental disorder—Methotrexate—lung cancer	0.000208	0.00047	CcSEcCtD
Etonogestrel—Rash—Gemcitabine—lung cancer	0.000208	0.00047	CcSEcCtD
Etonogestrel—Dermatitis—Gemcitabine—lung cancer	0.000208	0.00047	CcSEcCtD
Etonogestrel—Hypersensitivity—Etoposide—lung cancer	0.000208	0.000469	CcSEcCtD
Etonogestrel—Erythema—Methotrexate—lung cancer	0.000207	0.000467	CcSEcCtD
Etonogestrel—Malnutrition—Methotrexate—lung cancer	0.000207	0.000467	CcSEcCtD
Etonogestrel—Haemoglobin—Doxorubicin—lung cancer	0.000207	0.000467	CcSEcCtD
Etonogestrel—Headache—Gemcitabine—lung cancer	0.000207	0.000467	CcSEcCtD
Etonogestrel—Rhinitis—Doxorubicin—lung cancer	0.000207	0.000466	CcSEcCtD
Etonogestrel—Dyspepsia—Docetaxel—lung cancer	0.000206	0.000466	CcSEcCtD
Etonogestrel—Haemorrhage—Doxorubicin—lung cancer	0.000206	0.000465	CcSEcCtD
Etonogestrel—Hypoaesthesia—Doxorubicin—lung cancer	0.000205	0.000463	CcSEcCtD
Etonogestrel—Pharyngitis—Doxorubicin—lung cancer	0.000205	0.000461	CcSEcCtD
Etonogestrel—Decreased appetite—Docetaxel—lung cancer	0.000204	0.00046	CcSEcCtD
Etonogestrel—Hypersensitivity—Paclitaxel—lung cancer	0.000204	0.00046	CcSEcCtD
Etonogestrel—Norethindrone—ALB—lung cancer	0.000204	0.138	CrCbGaD
Etonogestrel—Urinary tract disorder—Doxorubicin—lung cancer	0.000204	0.000459	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Docetaxel—lung cancer	0.000203	0.000457	CcSEcCtD
Etonogestrel—Asthenia—Etoposide—lung cancer	0.000203	0.000457	CcSEcCtD
Etonogestrel—Connective tissue disorder—Doxorubicin—lung cancer	0.000203	0.000457	CcSEcCtD
Etonogestrel—Fatigue—Docetaxel—lung cancer	0.000202	0.000456	CcSEcCtD
Etonogestrel—Ethinyl Estradiol—ABCB1—lung cancer	0.000202	0.137	CrCbGaD
Etonogestrel—Urethral disorder—Doxorubicin—lung cancer	0.000202	0.000456	CcSEcCtD
Etonogestrel—Nausea—Irinotecan—lung cancer	0.000202	0.000455	CcSEcCtD
Etonogestrel—Testosterone—CYP1A1—lung cancer	0.000201	0.137	CrCbGaD
Etonogestrel—Pain—Docetaxel—lung cancer	0.000201	0.000453	CcSEcCtD
Etonogestrel—Constipation—Docetaxel—lung cancer	0.000201	0.000453	CcSEcCtD
Etonogestrel—Back pain—Methotrexate—lung cancer	0.0002	0.000452	CcSEcCtD
Etonogestrel—Pruritus—Etoposide—lung cancer	0.0002	0.000451	CcSEcCtD
Etonogestrel—Visual impairment—Doxorubicin—lung cancer	0.000199	0.000448	CcSEcCtD
Etonogestrel—Asthenia—Paclitaxel—lung cancer	0.000199	0.000448	CcSEcCtD
Etonogestrel—Nausea—Gemcitabine—lung cancer	0.000196	0.000443	CcSEcCtD
Etonogestrel—Vomiting—Cisplatin—lung cancer	0.000196	0.000442	CcSEcCtD
Etonogestrel—Pruritus—Paclitaxel—lung cancer	0.000196	0.000442	CcSEcCtD
Etonogestrel—Norethindrone—ABCB1—lung cancer	0.000194	0.132	CrCbGaD
Etonogestrel—Rash—Cisplatin—lung cancer	0.000194	0.000438	CcSEcCtD
Etonogestrel—Dermatitis—Cisplatin—lung cancer	0.000194	0.000438	CcSEcCtD
Etonogestrel—Methyltestosterone—ALB—lung cancer	0.000193	0.131	CrCbGaD
Etonogestrel—Feeling abnormal—Docetaxel—lung cancer	0.000193	0.000436	CcSEcCtD
Etonogestrel—Diarrhoea—Etoposide—lung cancer	0.000193	0.000436	CcSEcCtD
Etonogestrel—Eye disorder—Doxorubicin—lung cancer	0.000193	0.000435	CcSEcCtD
Etonogestrel—Ill-defined disorder—Methotrexate—lung cancer	0.000192	0.000434	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Docetaxel—lung cancer	0.000192	0.000433	CcSEcCtD
Etonogestrel—Diarrhoea—Paclitaxel—lung cancer	0.000189	0.000427	CcSEcCtD
Etonogestrel—Angiopathy—Doxorubicin—lung cancer	0.000187	0.000422	CcSEcCtD
Etonogestrel—Malaise—Methotrexate—lung cancer	0.000187	0.000422	CcSEcCtD
Etonogestrel—Dizziness—Etoposide—lung cancer	0.000187	0.000421	CcSEcCtD
Etonogestrel—Immune system disorder—Doxorubicin—lung cancer	0.000186	0.00042	CcSEcCtD
Etonogestrel—Body temperature increased—Docetaxel—lung cancer	0.000185	0.000418	CcSEcCtD
Etonogestrel—Abdominal pain—Docetaxel—lung cancer	0.000185	0.000418	CcSEcCtD
Etonogestrel—Dizziness—Paclitaxel—lung cancer	0.000183	0.000413	CcSEcCtD
Etonogestrel—Nausea—Cisplatin—lung cancer	0.000183	0.000413	CcSEcCtD
Etonogestrel—Alopecia—Doxorubicin—lung cancer	0.000182	0.000411	CcSEcCtD
Etonogestrel—Cough—Methotrexate—lung cancer	0.000181	0.000408	CcSEcCtD
Etonogestrel—Mental disorder—Doxorubicin—lung cancer	0.000181	0.000407	CcSEcCtD
Etonogestrel—Convulsion—Methotrexate—lung cancer	0.000179	0.000405	CcSEcCtD
Etonogestrel—Vomiting—Etoposide—lung cancer	0.000179	0.000405	CcSEcCtD
Etonogestrel—Malnutrition—Doxorubicin—lung cancer	0.000179	0.000405	CcSEcCtD
Etonogestrel—Erythema—Doxorubicin—lung cancer	0.000179	0.000405	CcSEcCtD
Etonogestrel—Rash—Etoposide—lung cancer	0.000178	0.000402	CcSEcCtD
Etonogestrel—Dermatitis—Etoposide—lung cancer	0.000178	0.000401	CcSEcCtD
Etonogestrel—Headache—Etoposide—lung cancer	0.000177	0.000399	CcSEcCtD
Etonogestrel—Flatulence—Doxorubicin—lung cancer	0.000177	0.000399	CcSEcCtD
Etonogestrel—Arthralgia—Methotrexate—lung cancer	0.000176	0.000398	CcSEcCtD
Etonogestrel—Myalgia—Methotrexate—lung cancer	0.000176	0.000398	CcSEcCtD
Etonogestrel—Tension—Doxorubicin—lung cancer	0.000176	0.000397	CcSEcCtD
Etonogestrel—Vomiting—Paclitaxel—lung cancer	0.000176	0.000397	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000175	0.000395	CcSEcCtD
Etonogestrel—Rash—Paclitaxel—lung cancer	0.000175	0.000394	CcSEcCtD
Etonogestrel—Dermatitis—Paclitaxel—lung cancer	0.000174	0.000393	CcSEcCtD
Etonogestrel—Discomfort—Methotrexate—lung cancer	0.000174	0.000393	CcSEcCtD
Etonogestrel—Nervousness—Doxorubicin—lung cancer	0.000174	0.000393	CcSEcCtD
Etonogestrel—Back pain—Doxorubicin—lung cancer	0.000174	0.000392	CcSEcCtD
Etonogestrel—Headache—Paclitaxel—lung cancer	0.000173	0.000391	CcSEcCtD
Etonogestrel—Hypersensitivity—Docetaxel—lung cancer	0.000173	0.00039	CcSEcCtD
Etonogestrel—Muscle spasms—Doxorubicin—lung cancer	0.000172	0.000389	CcSEcCtD
Etonogestrel—Anaphylactic shock—Methotrexate—lung cancer	0.000169	0.000382	CcSEcCtD
Etonogestrel—Asthenia—Docetaxel—lung cancer	0.000168	0.00038	CcSEcCtD
Etonogestrel—Infection—Methotrexate—lung cancer	0.000168	0.000379	CcSEcCtD
Etonogestrel—Nausea—Etoposide—lung cancer	0.000168	0.000378	CcSEcCtD
Etonogestrel—Ill-defined disorder—Doxorubicin—lung cancer	0.000166	0.000376	CcSEcCtD
Etonogestrel—Pruritus—Docetaxel—lung cancer	0.000166	0.000374	CcSEcCtD
Etonogestrel—Nervous system disorder—Methotrexate—lung cancer	0.000166	0.000374	CcSEcCtD
Etonogestrel—Nausea—Paclitaxel—lung cancer	0.000164	0.000371	CcSEcCtD
Etonogestrel—Skin disorder—Methotrexate—lung cancer	0.000164	0.000371	CcSEcCtD
Etonogestrel—Malaise—Doxorubicin—lung cancer	0.000162	0.000365	CcSEcCtD
Etonogestrel—Anorexia—Methotrexate—lung cancer	0.000161	0.000364	CcSEcCtD
Etonogestrel—Diarrhoea—Docetaxel—lung cancer	0.000161	0.000362	CcSEcCtD
Etonogestrel—Cough—Doxorubicin—lung cancer	0.000157	0.000353	CcSEcCtD
Etonogestrel—Convulsion—Doxorubicin—lung cancer	0.000155	0.000351	CcSEcCtD
Etonogestrel—Dizziness—Docetaxel—lung cancer	0.000155	0.00035	CcSEcCtD
Etonogestrel—Hypertension—Doxorubicin—lung cancer	0.000155	0.000349	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000154	0.000348	CcSEcCtD
Etonogestrel—Insomnia—Methotrexate—lung cancer	0.000153	0.000345	CcSEcCtD
Etonogestrel—Arthralgia—Doxorubicin—lung cancer	0.000153	0.000345	CcSEcCtD
Etonogestrel—Myalgia—Doxorubicin—lung cancer	0.000153	0.000345	CcSEcCtD
Etonogestrel—Anxiety—Doxorubicin—lung cancer	0.000152	0.000343	CcSEcCtD
Etonogestrel—Paraesthesia—Methotrexate—lung cancer	0.000152	0.000343	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000152	0.000342	CcSEcCtD
Etonogestrel—Discomfort—Doxorubicin—lung cancer	0.000151	0.00034	CcSEcCtD
Etonogestrel—Somnolence—Methotrexate—lung cancer	0.00015	0.000339	CcSEcCtD
Etonogestrel—Vomiting—Docetaxel—lung cancer	0.000149	0.000337	CcSEcCtD
Etonogestrel—Dyspepsia—Methotrexate—lung cancer	0.000149	0.000336	CcSEcCtD
Etonogestrel—Rash—Docetaxel—lung cancer	0.000148	0.000334	CcSEcCtD
Etonogestrel—Dermatitis—Docetaxel—lung cancer	0.000148	0.000333	CcSEcCtD
Etonogestrel—Decreased appetite—Methotrexate—lung cancer	0.000147	0.000332	CcSEcCtD
Etonogestrel—Headache—Docetaxel—lung cancer	0.000147	0.000332	CcSEcCtD
Etonogestrel—Anaphylactic shock—Doxorubicin—lung cancer	0.000146	0.00033	CcSEcCtD
Etonogestrel—Oedema—Doxorubicin—lung cancer	0.000146	0.00033	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Methotrexate—lung cancer	0.000146	0.000329	CcSEcCtD
Etonogestrel—Fatigue—Methotrexate—lung cancer	0.000146	0.000329	CcSEcCtD
Etonogestrel—Infection—Doxorubicin—lung cancer	0.000145	0.000328	CcSEcCtD
Etonogestrel—Pain—Methotrexate—lung cancer	0.000145	0.000326	CcSEcCtD
Etonogestrel—Nervous system disorder—Doxorubicin—lung cancer	0.000144	0.000324	CcSEcCtD
Etonogestrel—Skin disorder—Doxorubicin—lung cancer	0.000142	0.000321	CcSEcCtD
Etonogestrel—Anorexia—Doxorubicin—lung cancer	0.00014	0.000315	CcSEcCtD
Etonogestrel—Nausea—Docetaxel—lung cancer	0.000139	0.000314	CcSEcCtD
Etonogestrel—Feeling abnormal—Methotrexate—lung cancer	0.000139	0.000314	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Methotrexate—lung cancer	0.000138	0.000312	CcSEcCtD
Etonogestrel—Urticaria—Methotrexate—lung cancer	0.000134	0.000303	CcSEcCtD
Etonogestrel—Abdominal pain—Methotrexate—lung cancer	0.000134	0.000302	CcSEcCtD
Etonogestrel—Body temperature increased—Methotrexate—lung cancer	0.000134	0.000302	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000133	0.000301	CcSEcCtD
Etonogestrel—Insomnia—Doxorubicin—lung cancer	0.000132	0.000299	CcSEcCtD
Etonogestrel—Paraesthesia—Doxorubicin—lung cancer	0.000131	0.000297	CcSEcCtD
Etonogestrel—Somnolence—Doxorubicin—lung cancer	0.00013	0.000294	CcSEcCtD
Etonogestrel—Dyspepsia—Doxorubicin—lung cancer	0.000129	0.000291	CcSEcCtD
Etonogestrel—Decreased appetite—Doxorubicin—lung cancer	0.000127	0.000287	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000126	0.000285	CcSEcCtD
Etonogestrel—Fatigue—Doxorubicin—lung cancer	0.000126	0.000285	CcSEcCtD
Etonogestrel—Pain—Doxorubicin—lung cancer	0.000125	0.000282	CcSEcCtD
Etonogestrel—Constipation—Doxorubicin—lung cancer	0.000125	0.000282	CcSEcCtD
Etonogestrel—Hypersensitivity—Methotrexate—lung cancer	0.000125	0.000281	CcSEcCtD
Etonogestrel—Asthenia—Methotrexate—lung cancer	0.000121	0.000274	CcSEcCtD
Etonogestrel—Feeling abnormal—Doxorubicin—lung cancer	0.000121	0.000272	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Doxorubicin—lung cancer	0.00012	0.00027	CcSEcCtD
Etonogestrel—Pruritus—Methotrexate—lung cancer	0.00012	0.00027	CcSEcCtD
Etonogestrel—Urticaria—Doxorubicin—lung cancer	0.000116	0.000262	CcSEcCtD
Etonogestrel—Body temperature increased—Doxorubicin—lung cancer	0.000116	0.000261	CcSEcCtD
Etonogestrel—Abdominal pain—Doxorubicin—lung cancer	0.000116	0.000261	CcSEcCtD
Etonogestrel—Diarrhoea—Methotrexate—lung cancer	0.000116	0.000261	CcSEcCtD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—VEGFA—lung cancer	0.000114	0.000709	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PXN—lung cancer	0.000112	0.000702	CbGpPWpGaD
Etonogestrel—Testosterone—ALB—lung cancer	0.000112	0.0762	CrCbGaD
Etonogestrel—PGR—Gene Expression—JUNB—lung cancer	0.000112	0.000698	CbGpPWpGaD
Etonogestrel—Dizziness—Methotrexate—lung cancer	0.000112	0.000252	CcSEcCtD
Etonogestrel—ESR1—Signaling by ERBB4—NRAS—lung cancer	0.000112	0.000697	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	0.000111	0.000692	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—AKR1C1—lung cancer	0.00011	0.000687	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—GRP—lung cancer	0.00011	0.000687	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—OXTR—lung cancer	0.00011	0.000687	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	0.000108	0.000674	CbGpPWpGaD
Etonogestrel—Hypersensitivity—Doxorubicin—lung cancer	0.000108	0.000243	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	0.000108	0.000672	CbGpPWpGaD
Etonogestrel—Vomiting—Methotrexate—lung cancer	0.000108	0.000243	CcSEcCtD
Etonogestrel—Testosterone—ABCB1—lung cancer	0.000107	0.0727	CrCbGaD
Etonogestrel—ESR1—Signaling by ERBB4—MAPK3—lung cancer	0.000107	0.000667	CbGpPWpGaD
Etonogestrel—Rash—Methotrexate—lung cancer	0.000107	0.000241	CcSEcCtD
Etonogestrel—Dermatitis—Methotrexate—lung cancer	0.000107	0.00024	CcSEcCtD
Etonogestrel—Headache—Methotrexate—lung cancer	0.000106	0.000239	CcSEcCtD
Etonogestrel—Asthenia—Doxorubicin—lung cancer	0.000105	0.000237	CcSEcCtD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—MYC—lung cancer	0.000105	0.000652	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	0.000104	0.000652	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	0.000104	0.00065	CbGpPWpGaD
Etonogestrel—Pruritus—Doxorubicin—lung cancer	0.000104	0.000234	CcSEcCtD
Etonogestrel—PGR—Signaling Pathways—GNG11—lung cancer	0.000103	0.000643	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—EGFR—lung cancer	0.000102	0.000638	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—EGFR—lung cancer	0.000102	0.000635	CbGpPWpGaD
Etonogestrel—Nausea—Methotrexate—lung cancer	0.0001	0.000227	CcSEcCtD
Etonogestrel—Diarrhoea—Doxorubicin—lung cancer	0.0001	0.000226	CcSEcCtD
Etonogestrel—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	0.0001	0.000624	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	9.94e-05	0.00062	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—CYP2E1—lung cancer	9.91e-05	0.000619	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—VEGFC—lung cancer	9.82e-05	0.000613	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	9.78e-05	0.00061	CbGpPWpGaD
Etonogestrel—Dizziness—Doxorubicin—lung cancer	9.68e-05	0.000218	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	9.66e-05	0.000603	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—KRAS—lung cancer	9.66e-05	0.000603	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—KRAS—lung cancer	9.61e-05	0.0006	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—COL4A2—lung cancer	9.47e-05	0.000591	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	9.41e-05	0.000587	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—RARB—lung cancer	9.39e-05	0.000586	CbGpPWpGaD
Etonogestrel—Vomiting—Doxorubicin—lung cancer	9.31e-05	0.00021	CcSEcCtD
Etonogestrel—PGR—Signaling Pathways—ADCY1—lung cancer	9.27e-05	0.000578	CbGpPWpGaD
Etonogestrel—Rash—Doxorubicin—lung cancer	9.23e-05	0.000208	CcSEcCtD
Etonogestrel—ESR1—Signaling Pathways—GIPR—lung cancer	9.23e-05	0.000576	CbGpPWpGaD
Etonogestrel—Dermatitis—Doxorubicin—lung cancer	9.22e-05	0.000208	CcSEcCtD
Etonogestrel—Headache—Doxorubicin—lung cancer	9.17e-05	0.000207	CcSEcCtD
Etonogestrel—ESR1—Gene Expression—NPPA—lung cancer	9.15e-05	0.000571	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PPP2R1B—lung cancer	9.03e-05	0.000564	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—SMARCA4—lung cancer	9.03e-05	0.000564	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	8.9e-05	0.000556	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—PIK3CA—lung cancer	8.83e-05	0.000551	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HSPB1—lung cancer	8.72e-05	0.000544	CbGpPWpGaD
Etonogestrel—Nausea—Doxorubicin—lung cancer	8.7e-05	0.000196	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	8.66e-05	0.00054	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PTHLH—lung cancer	8.62e-05	0.000538	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SDC4—lung cancer	8.62e-05	0.000538	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—TP53—lung cancer	8.58e-05	0.000536	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	8.47e-05	0.000529	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—DUSP3—lung cancer	8.44e-05	0.000527	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—RHEB—lung cancer	8.28e-05	0.000517	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—GSTP1—lung cancer	8.18e-05	0.00051	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—HRAS—lung cancer	8.17e-05	0.00051	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—ERCC2—lung cancer	8.12e-05	0.000507	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ANXA1—lung cancer	8.1e-05	0.000506	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	8.06e-05	0.000503	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	8e-05	0.000499	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—HSPB1—lung cancer	7.87e-05	0.000491	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GRM8—lung cancer	7.85e-05	0.00049	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—FLT1—lung cancer	7.85e-05	0.00049	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—IL6—lung cancer	7.82e-05	0.000488	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NOTCH3—lung cancer	7.68e-05	0.000479	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—APP—lung cancer	7.68e-05	0.000479	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—FGF9—lung cancer	7.62e-05	0.000475	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SKI—lung cancer	7.6e-05	0.000474	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—GSTM1—lung cancer	7.51e-05	0.000469	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	7.41e-05	0.000462	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	7.35e-05	0.000459	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—MYC—lung cancer	7.33e-05	0.000457	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—JUNB—lung cancer	7.27e-05	0.000454	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—CREBBP—lung cancer	7.25e-05	0.000452	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—AKT1—lung cancer	7.25e-05	0.000452	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—AKT1—lung cancer	7.21e-05	0.00045	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—CYP1A1—lung cancer	7.12e-05	0.000445	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	7.11e-05	0.000444	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	7.03e-05	0.000438	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—NOTCH3—lung cancer	6.93e-05	0.000433	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—STK11—lung cancer	6.6e-05	0.000412	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PXN—lung cancer	6.6e-05	0.000412	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—JUNB—lung cancer	6.57e-05	0.00041	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—AKR1C1—lung cancer	6.46e-05	0.000403	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GRP—lung cancer	6.46e-05	0.000403	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—OXTR—lung cancer	6.46e-05	0.000403	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—FOXO3—lung cancer	6.37e-05	0.000398	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—AZIN2—lung cancer	6.27e-05	0.000391	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—COL4A3BP—lung cancer	6.27e-05	0.000391	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GNG11—lung cancer	6.05e-05	0.000378	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	6.01e-05	0.000375	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—AVP—lung cancer	5.97e-05	0.000373	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—CREBBP—lung cancer	5.95e-05	0.000371	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—VEGFC—lung cancer	5.76e-05	0.00036	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IGF1R—lung cancer	5.75e-05	0.000359	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HES1—lung cancer	5.65e-05	0.000353	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ADCY1—lung cancer	5.44e-05	0.00034	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ATP5H—lung cancer	5.33e-05	0.000332	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—POMC—lung cancer	5.31e-05	0.000331	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PPP2R1B—lung cancer	5.3e-05	0.000331	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SMARCA4—lung cancer	5.3e-05	0.000331	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ERBB3—lung cancer	5.16e-05	0.000322	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HSPB1—lung cancer	5.12e-05	0.000319	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PTHLH—lung cancer	5.06e-05	0.000316	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TERT—lung cancer	4.95e-05	0.000309	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—FGFR1—lung cancer	4.81e-05	0.0003	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—ERCC2—lung cancer	4.77e-05	0.000297	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ANXA1—lung cancer	4.76e-05	0.000297	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PLBD1—lung cancer	4.75e-05	0.000296	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HIF1A—lung cancer	4.73e-05	0.000295	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FLT1—lung cancer	4.61e-05	0.000287	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—APOA1—lung cancer	4.57e-05	0.000285	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—KDR—lung cancer	4.53e-05	0.000283	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—APP—lung cancer	4.51e-05	0.000281	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NOTCH3—lung cancer	4.51e-05	0.000281	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FGF9—lung cancer	4.47e-05	0.000279	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—HSD17B10—lung cancer	4.34e-05	0.000271	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—MYC—lung cancer	4.3e-05	0.000268	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—JUNB—lung cancer	4.27e-05	0.000266	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—APC—lung cancer	4.17e-05	0.00026	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PIK3CG—lung cancer	4.17e-05	0.00026	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—KIT—lung cancer	4.17e-05	0.00026	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—EGF—lung cancer	4.12e-05	0.000257	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CKB—lung cancer	4.04e-05	0.000252	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—POMC—lung cancer	3.97e-05	0.000248	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—BRAF—lung cancer	3.92e-05	0.000245	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—STK11—lung cancer	3.88e-05	0.000242	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IL6R—lung cancer	3.87e-05	0.000242	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CREBBP—lung cancer	3.87e-05	0.000241	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTM2—lung cancer	3.8e-05	0.000237	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CNDP2—lung cancer	3.8e-05	0.000237	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FOXO3—lung cancer	3.74e-05	0.000233	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—MTMR3—lung cancer	3.69e-05	0.00023	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MAP2K1—lung cancer	3.69e-05	0.00023	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PIK3CD—lung cancer	3.67e-05	0.000229	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—MAPK3—lung cancer	3.63e-05	0.000226	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PGAM1—lung cancer	3.6e-05	0.000225	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—MYC—lung cancer	3.53e-05	0.00022	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—AVP—lung cancer	3.51e-05	0.000219	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—CREBBP—lung cancer	3.49e-05	0.000218	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYP2A7—lung cancer	3.43e-05	0.000214	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IGF1R—lung cancer	3.37e-05	0.000211	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—SDC4—lung cancer	3.36e-05	0.00021	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HES1—lung cancer	3.32e-05	0.000207	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MDM2—lung cancer	3.28e-05	0.000205	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—RAF1—lung cancer	3.27e-05	0.000204	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ERBB2—lung cancer	3.24e-05	0.000202	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MTOR—lung cancer	3.2e-05	0.000199	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PIK3CB—lung cancer	3.2e-05	0.000199	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CXCL8—lung cancer	3.07e-05	0.000192	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTA3—lung cancer	3.06e-05	0.000191	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—RRM1—lung cancer	3.06e-05	0.000191	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ERBB3—lung cancer	3.03e-05	0.000189	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CASP3—lung cancer	2.94e-05	0.000183	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IL2—lung cancer	2.93e-05	0.000183	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TERT—lung cancer	2.9e-05	0.000181	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—B4GALT5—lung cancer	2.88e-05	0.00018	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CCND1—lung cancer	2.86e-05	0.000179	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—JUN—lung cancer	2.85e-05	0.000178	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FGFR1—lung cancer	2.82e-05	0.000176	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTA4—lung cancer	2.8e-05	0.000175	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HIF1A—lung cancer	2.78e-05	0.000173	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MMP9—lung cancer	2.78e-05	0.000173	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CDKN1A—lung cancer	2.77e-05	0.000173	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PTEN—lung cancer	2.76e-05	0.000172	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTA2—lung cancer	2.73e-05	0.00017	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—APOA1—lung cancer	2.68e-05	0.000167	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—KDR—lung cancer	2.66e-05	0.000166	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—EP300—lung cancer	2.63e-05	0.000164	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTA1—lung cancer	2.63e-05	0.000164	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ABCC3—lung cancer	2.6e-05	0.000162	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—SRC—lung cancer	2.56e-05	0.00016	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—AKR1C1—lung cancer	2.52e-05	0.000157	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—VEGFA—lung cancer	2.49e-05	0.000156	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—STAT3—lung cancer	2.47e-05	0.000154	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NRAS—lung cancer	2.46e-05	0.000154	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—APC—lung cancer	2.45e-05	0.000153	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—KIT—lung cancer	2.45e-05	0.000153	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PIK3CG—lung cancer	2.45e-05	0.000153	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—AKT1—lung cancer	2.45e-05	0.000153	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—UGT1A1—lung cancer	2.45e-05	0.000153	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—EGF—lung cancer	2.42e-05	0.000151	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MAPK3—lung cancer	2.36e-05	0.000147	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GNG11—lung cancer	2.36e-05	0.000147	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—POMC—lung cancer	2.33e-05	0.000145	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—BRAF—lung cancer	2.3e-05	0.000144	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MYC—lung cancer	2.29e-05	0.000143	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IL6R—lung cancer	2.27e-05	0.000142	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CREBBP—lung cancer	2.27e-05	0.000142	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ALDOA—lung cancer	2.25e-05	0.00014	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—EGFR—lung cancer	2.24e-05	0.00014	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—NCOA3—lung cancer	2.18e-05	0.000136	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MAP2K1—lung cancer	2.17e-05	0.000135	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PIK3CD—lung cancer	2.15e-05	0.000134	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—MAPK3—lung cancer	2.13e-05	0.000133	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ADCY1—lung cancer	2.12e-05	0.000132	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ABCG2—lung cancer	2.12e-05	0.000132	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—KRAS—lung cancer	2.12e-05	0.000132	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ENO2—lung cancer	2.08e-05	0.00013	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—HPGDS—lung cancer	2.08e-05	0.00013	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—MYC—lung cancer	2.07e-05	0.000129	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PPP2R1B—lung cancer	2.07e-05	0.000129	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTT1—lung cancer	2.02e-05	0.000126	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYP2A6—lung cancer	1.99e-05	0.000124	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GCLC—lung cancer	1.99e-05	0.000124	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PIK3CA—lung cancer	1.95e-05	0.000122	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MDM2—lung cancer	1.93e-05	0.00012	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—RAF1—lung cancer	1.92e-05	0.00012	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ERBB2—lung cancer	1.9e-05	0.000119	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ENO1—lung cancer	1.89e-05	0.000118	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TP53—lung cancer	1.88e-05	0.000118	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MTOR—lung cancer	1.88e-05	0.000117	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PIK3CB—lung cancer	1.88e-05	0.000117	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CXCL8—lung cancer	1.8e-05	0.000112	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HRAS—lung cancer	1.8e-05	0.000112	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CASP3—lung cancer	1.72e-05	0.000108	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IL6—lung cancer	1.72e-05	0.000108	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IL2—lung cancer	1.72e-05	0.000107	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYP2E1—lung cancer	1.7e-05	0.000106	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CCND1—lung cancer	1.68e-05	0.000105	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—NQO1—lung cancer	1.68e-05	0.000105	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—JUN—lung cancer	1.68e-05	0.000105	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MMP9—lung cancer	1.63e-05	0.000102	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CDKN1A—lung cancer	1.62e-05	0.000101	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PTEN—lung cancer	1.62e-05	0.000101	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—AKT1—lung cancer	1.59e-05	9.93e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—EP300—lung cancer	1.55e-05	9.64e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—STK11—lung cancer	1.51e-05	9.43e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SRC—lung cancer	1.5e-05	9.38e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—VEGFA—lung cancer	1.46e-05	9.13e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—STAT3—lung cancer	1.45e-05	9.04e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NRAS—lung cancer	1.45e-05	9.02e-05	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—AKT1—lung cancer	1.44e-05	8.96e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTP1—lung cancer	1.4e-05	8.73e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MAPK3—lung cancer	1.38e-05	8.64e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CAT—lung cancer	1.36e-05	8.49e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MYC—lung cancer	1.35e-05	8.4e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ABCB1—lung cancer	1.32e-05	8.26e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—EGFR—lung cancer	1.32e-05	8.22e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—TYMS—lung cancer	1.3e-05	8.11e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTM1—lung cancer	1.28e-05	8.02e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—KRAS—lung cancer	1.24e-05	7.77e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYP1A1—lung cancer	1.22e-05	7.6e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ERCC2—lung cancer	1.21e-05	7.54e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PIK3CA—lung cancer	1.14e-05	7.13e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TP53—lung cancer	1.11e-05	6.9e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HRAS—lung cancer	1.06e-05	6.6e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—APOA1—lung cancer	1.05e-05	6.52e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IL6—lung cancer	1.01e-05	6.32e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PIK3CG—lung cancer	9.54e-06	5.95e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—AKT1—lung cancer	9.34e-06	5.83e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—POMC—lung cancer	9.08e-06	5.67e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CREBBP—lung cancer	8.85e-06	5.52e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PIK3CD—lung cancer	8.39e-06	5.23e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ALB—lung cancer	8.28e-06	5.17e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PIK3CB—lung cancer	7.31e-06	4.56e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PTGS2—lung cancer	7.24e-06	4.52e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PTEN—lung cancer	6.32e-06	3.94e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—EP300—lung cancer	6.02e-06	3.76e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PIK3CA—lung cancer	4.46e-06	2.78e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—AKT1—lung cancer	3.64e-06	2.27e-05	CbGpPWpGaD
